Last reviewed · How we verify
Adhesive capsulitis of shoulder — Treatment Landscape & Competitive Intelligence
2 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Voltaren | DICLOFENAC | Hisamitsu Pharmaceutical Co., Inc | Nonsteroidal Anti-inflammatory Drug | Prostaglandin G/H synthase 2 | 1988-01-01 | |
| Arthrotec | Diclofenac Sodium | Pfizer | diclofenac | Acid-sensing ion channel 3 | 1988-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 1 drug in Adhesive capsulitis of shoulder
- Hisamitsu Pharmaceutical Co., Inc · 1 drug in Adhesive capsulitis of shoulder
- Pfizer · 1 drug in Adhesive capsulitis of shoulder
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Adhesive capsulitis of shoulder:
- Adhesive capsulitis of shoulder treatment updates — RSS
- Adhesive capsulitis of shoulder treatment updates — Atom
- Adhesive capsulitis of shoulder treatment updates — JSON
Cite this brief
Drug Landscape (2026). Adhesive capsulitis of shoulder — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/adhesive-capsulitis-of-shoulder. Accessed 2026-06-10.
Related
- Adhesive capsulitis of shoulder full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing